Log In
person
Karyopharm Therapeutics Inc
KPTI
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Oncology Pharma |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
112.01M | 76.70% |
| Oncology Pharma |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
34.02M | 23.30% |
| keyboard_arrow_down |
Oncology Pharma
Branded Pharmaceuticals (outsourced)
|
112.01M | 76.70% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Oncology Pharma
Pharmaceutical Patent Licensing
|
34.02M | 23.30% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||